Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
combination therapy
Research
Approved IBS drug may help overcome prostate cancer resistance
A drug used to treat irritable bowel syndrome appears to be effective against prostate cancer in mice when given in tandem with chemotherapy.
Helen Floersh
Jan 22, 2024 11:00am
First-in-class drug halts breast and ovarian cancer in mice
Oct 27, 2023 7:45am
ALX follows Gilead in axing cancer trials as data disappoint
Aug 11, 2023 9:05am
NIH precision medicine initiative tests preclinical drug combos
Jun 5, 2023 11:21am
Ultimovacs delays cancer vaccine readout over sluggish melanoma
Apr 25, 2023 6:10am
Merck's Keytruda combo tacks on another loss for TIGIT class
Mar 16, 2023 4:05pm